PanGO Medical Devices Inc.

Belkins
PanGO Medical specializes in biomedical research and diagnostics instrumentation, and we have the resources and expertise to provide a range of services --- from niche consultation by our scientists on medical technologies such as optics, electrochemistry, spectrometry, and fluidics, to full turn-key solutions for design, development, and manufacturing.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

UPADHYE CWIK LLP GUIDES ABOUT INNOVATIVE LEGAL PRACTICES ON PHARMACEUTICAL AND FDA ISSUES IN COVID-19 WORLD

Upadhye Cwik LLP | July 02, 2020

news image

The COVID-19 pandemic continues to turn the world upside down. And when upside down, the legal issues surrounding pharmaceuticals and the FDA become apparent. We identify a few areas that our law firm is working on for clients. Our patent work remains busy helping clients with rationalizing patent portfolios, conducting infringement-mapping exercises to find potential licensing revenues, and patent litigation to enforce patent rights. Interestingly we see some clients not cutting ...

Read More

RESEARCH

RHYTHM PHARMACEUTICALS RECEIVES FDA APPROVAL FOR OBESITY MED TARGETING GENETIC DEFECTS

Rhythm | December 01, 2020

news image

Stoutness is a significant issue around the world, in any case, for a small amount of patients, hereditary changes instead of propensities are driving the sickness. With its new FDA endorsement for Imcivree, Rhythm Pharmaceuticals is venturing out treating those cases. For a subset of heftiness patients, hereditary transformations leave them with an "voracious appetite," Rhythm CEO David Meeker, M.D., said in a meeting. Beginning stage hereditary illnesses can leave pati...

Read More

US AND UK 'LEAD PUSH AGAINST GLOBAL PATENT POOL FOR COVID-19 DRUGS'

The guardian | May 18, 2020

news image

Ministers and officials from every nation will meet via video link on Monday for the annual world health assembly, which is expected to be dominated by efforts to stop rich countries monopolising drugs and future vaccines against Covid-19. As some countries buy up drugs thought to be useful against the coronavirus, causing global shortages, and the Trump administration does deals with vaccine companies to supply America first, there is dismay among public health experts and campaigners who belie...

Read More

ASHP DEMANDS MORE MANUFACTURING OF VENTILATOR DRUGS FOR COVID-19

PharmaNewsIntelligence | April 07, 2020

news image

ASHP recently urged the Trump administration to take action to address shortages of supportive ventilator drugs as the number of confirmed COVID-19 cases continues to rise. The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more patients. In an official letter to Vice President Mike Pence, ASHP requested the administration release drugs from the Strategic Na...

Read More

Upadhye Cwik LLP | July 02, 2020

news image

UPADHYE CWIK LLP GUIDES ABOUT INNOVATIVE LEGAL PRACTICES ON PHARMACEUTICAL AND FDA ISSUES IN COVID-19 WORLD

The COVID-19 pandemic continues to turn the world upside down. And when upside down, the legal issues surrounding pharmaceuticals and the FDA become apparent. We identify a few areas that our law firm is working on for clients. Our patent work remains busy helping clients with rationalizing patent portfolios, conducting infringement-mapping exercises to find potential licensing revenues, and patent litigation to enforce patent rights. Interestingly we see some clients not cutting ...

Read More

RESEARCH

Rhythm | December 01, 2020

news image

RHYTHM PHARMACEUTICALS RECEIVES FDA APPROVAL FOR OBESITY MED TARGETING GENETIC DEFECTS

Stoutness is a significant issue around the world, in any case, for a small amount of patients, hereditary changes instead of propensities are driving the sickness. With its new FDA endorsement for Imcivree, Rhythm Pharmaceuticals is venturing out treating those cases. For a subset of heftiness patients, hereditary transformations leave them with an "voracious appetite," Rhythm CEO David Meeker, M.D., said in a meeting. Beginning stage hereditary illnesses can leave pati...

Read More

The guardian | May 18, 2020

news image

US AND UK 'LEAD PUSH AGAINST GLOBAL PATENT POOL FOR COVID-19 DRUGS'

Ministers and officials from every nation will meet via video link on Monday for the annual world health assembly, which is expected to be dominated by efforts to stop rich countries monopolising drugs and future vaccines against Covid-19. As some countries buy up drugs thought to be useful against the coronavirus, causing global shortages, and the Trump administration does deals with vaccine companies to supply America first, there is dismay among public health experts and campaigners who belie...

Read More

PharmaNewsIntelligence | April 07, 2020

news image

ASHP DEMANDS MORE MANUFACTURING OF VENTILATOR DRUGS FOR COVID-19

ASHP recently urged the Trump administration to take action to address shortages of supportive ventilator drugs as the number of confirmed COVID-19 cases continues to rise. The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more patients. In an official letter to Vice President Mike Pence, ASHP requested the administration release drugs from the Strategic Na...

Read More